amifostine anhydrous has been researched along with Paralysis in 1 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Paralysis: A general term most often used to describe severe or complete loss of muscle strength due to motor system disease from the level of the cerebral cortex to the muscle fiber. This term may also occasionally refer to a loss of sensory function. (From Adams et al., Principles of Neurology, 6th ed, p45)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Spence, AM | 1 |
| Krohn, KA | 1 |
| Steele, JE | 1 |
| Edmondson, SE | 1 |
| Rasey, JS | 1 |
1 other study available for amifostine anhydrous and Paralysis
| Article | Year |
|---|---|
WR-2721, WR-77913 and WR-3689 radioprotection in the rat spinal cord.
Topics: Amifostine; Animals; Cesium Radioisotopes; Female; Injections, Intraventricular; Paralysis; Radiatio | 1988 |